The Natural History of NAFLD, a Community‐Based Study at a Large Health Care Delivery System in the United States-Reference-Cited by-同舟云学术

The Natural History of NAFLD, a Community‐Based Study at a Large Health Care Delivery System in the United States

Published:2020-10-24 Issue:1 Volume:5 Page:83-96
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol. Commun.

Author:

Nyberg Lisa M.¹^ORCID,Cheetham T. Craig²^ORCID,Patton Heather M.¹^ORCID,Yang Su‐Jau³^ORCID,Chiang Kevin M.⁴^ORCID,Caparosa Susan L.³^ORCID,Stern Julie A.³^ORCID,Nyberg Anders H.¹^ORCID

Affiliation:

1. Gastroenterology/Hepatology Southern California Permanente Medical Group San Diego CA USA

2. Chapman University Orange CA USA

3. Department of Research and Evaluation Kaiser Permanente Southern California Pasadena CA USA

4. National Pharmacy Analytics Kaiser Permanente Downey CA USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1625

Reference45 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

4. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

5. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-09

2. Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis;The American Journal of Medicine;2024-07

3. Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions;CHILD`S HEALTH;2024-04-24

4. Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study;Alimentary Pharmacology & Therapeutics;2024-02

5. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action;Diabetes Spectrum;2024-02-01